Remdesivir: A Non-Antiviral Antiviral Drug?
There is an interesting line in the Chinese study on remdesivir that has gone almost entirely overlooked, one that introduces an interesting, and potentially serious, conundrum. The authors of the study wrote that “Remdesivir did not result in significant reductions in SARS-CoV-2 …
Urging Caution on Remdesivir
There is palpable excitement today among many regarding the potential of remdesivir to help patients with severe Covid-19 recover. Many are saying there is clear cut evidence that it works, based on a news release issued yesterday by the National Institutes of …
Reducing The Risk Of In Flight COVID-19 Transmission
All of us fly. Last year, more than 1.5 billion people took to the air. Flying both short and long distances has become a way of life not just for the privileged, but for the many. We always knew air travel was …
Reopening America will require this key thing that’s been ignored
Returning to work and school after the coronavirus is urgent and necessary. Virtually all public health officials agree on the three capabilities necessary to reopen society: Availability of tests to identify those actively infected and capable of infecting others. Exhaustive contract tracing …
Monoclonal Antibodies Could Help Fight Against Coronavirus
A group of Chinese scientists report the isolation of two human monoclonal antibodies with the potential to treat and to prevent SARS-CoV-2 infections, the causative agent of COVID-19. The work is described in a manuscript made available by Nature Cellular and Molecular …
Washington Post Column on Technology to Combat Covid-19 Features William A. Haseltine
The last time the United States faced a big, hard-to-track threat, we ended up with the Patriot Act and a mass-surveillance program that still rankles. This time, how do we use technology to combat the novel coronavirus without creating elements of a police state? …
We Need To Crush The Curve Now—Or COVID-19 Will Come Back To Haunt Us
In a bid to slow the spread of COVID-19, communities across the United States have taken action to “flatten the curve.” The curve in question represents the number of people predicted to contract the novel coronavirus over time, while attempts to flatten …
Why Researchers Are Exploring Antibodies From Recovered Patients For Possible Treatment And Prevention Of COVID-19
Is there a Covid-19 treatment that can treat critically ill, hospitalized patients, on the one hand, and protect healthcare workers on the other? Passive immune therapy has the potential to do both—immediately, and with major improvements over time. Broadly speaking, it involves …
Opportunity Lost: Avoiding Further Missteps With COVID-19 And Future Biothreats
“This is a tragedy that did not have to happen” was Governor of New York Andrew Cuomo’s plaintiff cry at the end of a recent broadcast. I echo his sentiment, not only for the delayed and ineffective action of our federal government …
Why Don’t We Have A Coronavirus Drug Yet—And How We Can Develop One As Soon As Possible
How will the new coronavirus pandemic end? It could prove to be seasonal, meaning it peters out with the weather with a chance of returning at this time next year. A significant plurality of all people on Earth could contract the disease—prolonging …
Recent Comments